Co-Principal Investigator of the Institute of Medicine (IOM) Mar. 1999 report titled “Marijuana and Medicine: Assessing the Science Base”
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
"The IOM report, Marijuana and Medicine: Assessing the Science Base, released in March 1999, found that marijuana's active components are potentially effective in treating pain, nausea and vomiting, AIDS-related loss of appetite, and other symptoms and should be tested rigorously in clinical trials. The therapeutic effects of smoked marijuana are typically modest, and in most cases there are more effective medicines. But a subpopulation of patients do not respond well to other medications and have no effective alternative to smoking marijuana."
Cowritten with John Benson and Janet Joy, "From Marijuana to Medicine," Issues in Science and Technology, Spring 1999
Key Experts Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
Co-Principal Investigator, Institute of Medicine (IOM) Mar. 1999 report titled “Marijuana and Medicine: Assessing the Science Base”
Co-director and Research Scientist, Molecular & Behavioral Neuroscience Institute, University of Michigan
Theophile Raphael Professor of Neurosciences in Psychiatry, Molecular & Behavioral Neuroscience Institute, University of Michigan
MD and PhD, schools unknown
Attended Tulane University School of Medicine, New Orleans
Residency, Psychiatry, Stanford University Hospital